Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

176 results about "Clinical disease" patented technology

Clinical disease: A disease that has recognizable clinical signs and symptoms, as distinct from a subclinical illness, which lacks detectable signs and symptoms. Diabetes, for example, can be a subclinical disease for some years before becoming a clinical disease.

Adverse drug reaction event identification method and system based on multivariate knowledge mixed retrieval enhancement

The invention discloses an adverse drug reaction event recognition method and system based on multivariate knowledge mixed retrieval enhancement, and the method comprises the steps: extracting drug entities from a to-be-recognized clinical disease course record, segmenting the disease course record, and obtaining a drug entity set and a sentence set; for each extracted drug entity, retrieving drug concept knowledge having a hyponymy relationship with the drug entity and drug adverse reaction knowledge having an adverse reaction relationship with the drug entity in a pre-constructed multivariate knowledge base; for each sentence obtained through segmentation, searching suspected adverse drug reaction events meeting a first similarity requirement and drug field text knowledge meeting a second similarity requirement in a pre-constructed multivariate knowledge base; and finally, calling a large language model, taking all the retrieved knowledge as reference knowledge, and identifying the adverse drug reaction event from the to-be-identified clinical disease course record. According to the invention, the accuracy and reliability of adverse drug reaction event identification can be improved.
Owner:CENT SOUTH UNIV

Clinical disease data integration-based image recognition model creation method

ActiveCN120563507AImage enhancementImage analysisBone morphologyBone structure
The invention relates to the technical field of model construction, in particular to a method for creating an image recognition model based on clinical disease data integration. The method comprises the following steps: acquiring a medical clinical orthopedic image set; the bone density and the bone form of the medical clinical orthopedic image set are extracted, bone structure division is carried out on the medical clinical orthopedic image set, bone structure division images are generated, and the bone structure division images comprise large bone structure images and small bone structure images; analyzing the bone layer thickness of the big bone structure image and performing physical layer thickness compensation reconstruction on the big bone structure image to generate big bone middle virtual slice data; and performing detail guide reconstruction on the small bone structure image to generate small bone fracture texture reconstruction data. According to the invention, through image resolution enhancement, multi-modal data integration, motion simulation and optimization model training, the accuracy of skeleton image dynamic identification is improved.
Owner:THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV

New method for intelligently evaluating early cognitive function of multi-modal Alzheimer's disease

InactiveCN120015297AMedical data miningEnsemble learningCognitive appraisalFeature extraction
The invention relates to the technical field of intelligent evaluation, in particular to a novel multi-modal Alzheimer's disease early cognitive function intelligent evaluation method, which comprises the steps of multi-modal data collection, data processing and feature extraction, and cognitive evaluation model construction. By collecting image data, facial recognition, linguistic and acoustic characteristics, exhaled gas components and eye movement and gait data under a double-task normal form, multi-aspect physiological and cognitive information of a patient is comprehensively collected by adopting a multi-modal data collection technology, and multi-modal information of the patient is acquired through multi-modal data. The evaluation method can more comprehensively reflect the cognitive state of a patient, predicts and automatically identifies abnormal cognitive performance through the cognitive evaluation model, can significantly improve the diagnosis sensitivity and specificity of the early cognitive impairment of the Alzheimer's disease, overcomes the limitation of a traditional single-mode evaluation method, and has a good application prospect in the field of diagnosis of early cognitive impairment of the Alzheimer's disease. And early discovery and early intervention of clinical diseases are effectively supported.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY

Nuclear medicine imaging method and system

The invention relates to the technical field of medical imaging, in particular to a nuclear medicine imaging method and system, and the method comprises the steps: patient preparation, tracer agent distribution detection, image enhancement, multi-target dynamic imaging, image quantitative analysis and data fusion, and result output and diagnosis suggestion. A preliminary image of tracer agent distribution in the body of a patient is obtained through a multi-modal imaging device, a high-resolution image is generated through a convolutional neural network noise suppression algorithm, a contrast ratio self-adaptive enhancement algorithm and a super-resolution reconstruction algorithm based on a generative adversarial network, and accurate dynamic analysis is carried out. In combination with a random forest algorithm and a time sequence analysis model, performing quantitative analysis on the radioactive intensity, the volume and the metabolic rate of the target spot, and generating personalized diagnosis suggestions; according to the invention, the precision and diagnosis effect of nuclear medicine imaging are greatly improved, and the method is suitable for early diagnosis, curative effect evaluation and disease progress monitoring of clinical diseases.
Owner:GUIZHOU PROVINCIAL PEOPLES HOSPITAL

BNP-targeted nano antibody as well as preparation method and application thereof

The invention discloses a nano antibody for targeting BNP (Brain Natriuretic Peptide) as well as a preparation method and application of the nano antibody. The amino acid sequences of CDR1, CDR2 and CDR3 of the nano antibody are respectively shown as SEQ ID NO: 1-3. The preparation method comprises the following steps: (1) constructing a prokaryotic expression vector and expressing recombinant protein by using an escherichia coli prokaryotic expression system; (2) carrying out alpaca immunization by utilizing the prepared recombinant protein to prepare a nano antibody library; (3) performing solid-phase panning of the nano antibody through a phage display system; (4) carrying out sequencing to obtain a nano antibody sequence, and then carrying out prokaryotic expression and identification; and (5) carrying out Western and Biacore identification to obtain the nano antibody which is combined with the BNP protein in a high affinity manner. The high-affinity nano antibody targeting the BNP is obtained, a tool can be provided for clinical disease diagnosis and treatment through in-vitro mass expression and transformation, and the high-affinity nano antibody has important commercial value.
Owner:NATIONAL INSTITUTE OF METROLOGY CHINA +1

Method and kit for detecting microrna

Provided is a method for detecting a microRNA. The method comprises: adding both (a) a polyadenylic acid tailing reaction system and (b) a reverse transcription reaction system to a sample to be detected, and subjecting the mixture to a one-step method by means of using a universal reverse transcription primer to obtain a reverse-transcribed cDNA product; and amplifying the product with a downstream universal primer and a specific upstream primer and detecting the amplified product with a universal fluorescence probe in a DNA amplification reaction and fluorescence detection system. Further provided is a kit based on the above-mentioned method. The provided method and kit have significantly higher sensitivity and specificity than traditional methods, can realize high-throughput sensitive detection with a small amount of samples, are convenient to operate and consume a short amount of time, and can detect batches of target microRNAs at low cost. Therefore, the provided method and kit are suitable for the screening of various biological samples, early diagnosis, companion diagnosis and prognosis evaluation of clinical diseases, etc.
Owner:ADVANCED PRECISION MEDICINE LTD

Method for using CBCT for automatically positioning tooth

The present invention relates to the technical field of dental medical treatment, and specifically discloses a method for using a CBCT (Cone Beam Computer Tomography) for automatically positioning a tooth, which comprises the following steps: S01, archiving CT data; S02, calculating AI and generating AI results; S03, entering CT reading by a client; S04, downloading and loading the CT data; S05, opening a function of a tooth lens; S06, selecting a corresponding tooth position in a tooth position list; and S07, selecting a 3D tooth rendering mode. The function of the ‘tooth lens’ is added into traditional CT reading, which is suitable for clinical disease diagnoses such as ‘tooth extraction, root canal therapy, tooth repair’ and the like in oral treatment, and doctors can precisely and quickly position the single tooth through selection for the tooth position, which facilitates more comprehensive analysis.
Owner:FUSSEN TECH CO LTD

Targeting Claudin18.2 nano antibody and application thereof

The invention discloses a Claudin18.2-targeting nano antibody and application thereof, and belongs to the technical field of molecular biology. Aiming at the unique advantages of a nano antibody in the prior art, the invention provides a nano antibody targeting Claudin18.2, the amino acid sequence of the targeting nano antibody is shown as SEQ ID NO.1, and the nano antibody has relatively strong affinity with Claudin18.2 positive cells 293T-Claudin18.2, and can be combined with Claudin18.2 protein expressed on the surfaces of the cells. The targeted Claudin18.2 nano antibody provided by the invention can be prepared through in-vitro engineering bacterium mass expression, can be applied to preparation of protein detection antibodies or therapeutic antibodies, can be used for in-vivo and in-vitro detection of tumor tissues expressed by Claudin18.2, and has important commercial value in clinical disease diagnosis and treatment.
Owner:HARBIN MEDICAL UNIVERSITY

Dual-system method for assessing transmissibility and disease severity of respiratory viruses

PendingUS20250298008A1Health-index calculationMicrobiological testing/measurementHuman airwayRespirovirus
The present invention uses ex vivo human airway cultures to assess the human transmissibility and replication competence of influenza and coronavirus strains. By comparing pandemic influenza A subtype H1N1 and highly pathogenic avian influenza H5N1 as reference strains, the transmissibility risk of various viruses was evaluated and categorized. Additionally, an in vitro model evaluated virus-induced impairment of alveolar fluid clearance (AFC) as an indicator of disease severity. The study revealed correlations between bronchus viral replication, human transmission, AFC impairment, and clinical disease severity across different influenza and coronavirus strains.
Owner:CENT FOR IMMUNOLOGY & INFECTION LTD

Construction and application of multidimensional medical big data fusion and disease prediction recognition engine

The invention provides construction and application of a multi-dimensional medical big data fusion and disease prediction recognition engine, and aims to fuse features of multi-dimensional medical data according to dimension weights through a pre-constructed factor group: F-F-form (q) so as to generate a targeted feature data set M (qt). And further performing prediction model training based on the feature data set M (qt), and putting the prediction model into clinical disease prediction application. Therefore, the fusion features are identified and learned through the model on the dimension weight, so that the learning efficiency of the model on the features is improved, the construction of the prediction model is accelerated, the application period of a clinical model is shortened, targeted disease prediction is performed by using the biased model generated by fusion, and disease prediction guidance in the clinical dimension is achieved.
Owner:FIRST HOSPITAL AFFILIATED TO GENERAL HOSPITAL OF PLA

Comprehensive health evaluation method and system based on in-vivo component metabolism multiple indexes

The invention discloses a comprehensive health evaluation method based on multiple indexes of in-vivo component metabolism. The method comprises the following steps: establishing an integrated model of a basic classification algorithm and a medical knowledge graph database; for the condition that in-vivo component metabolism indexes are sufficient and the disease classification labels of the medical knowledge map database can fully cover clinical diseases, predicting disease classification and health condition evaluation of the user based on an integrated model of a basic classification algorithm; otherwise, after variable self-adaptive addition of the fixed indexes and the user basic information indexes and automatic updating of the disease classification labels are carried out, the disease classification and health condition evaluation of the user are predicted; and collecting corresponding newly-added clinical user information by aiming at a fixed index adaptively added by a variable, a corresponding user basic information index and an automatically updated disease classification label, and adding non-existing entity nodes and relationships so as to form updating of the medical knowledge graph database. The invention further discloses a system, electronic equipment and a computer readable storage medium.
Owner:北京中生金域诊断技术股份有限公司

Blood transfusion intelligent decision-making system, device and method

The present invention relates to a blood transfusion intelligent decision-making system and method, which comprises a doctor user port, a system server and an external port set up in a hospital; its architecture comprises a data layer, an interaction layer, an application layer and peripheral system applications; in the data layer, a hospital information HIS system records patient information and diagnosis information; a laboratory / testing department information LIS system records blood type / indication detection information; a medical record EMR system records blood transfusion medical record information; a hospital blood transfusion TMIS system records patient historical blood transfusion information; a diagnosis and treatment IDT system records blood transfusion intelligent decision-making information; intelligent decision-making: based on patient information, a blood transfusion treatment plan recommendation is obtained through national blood transfusion specifications, blood transfusion standards and clinical disease type analysis; the present invention has reasonable design, compact structure and is easy to use.
Owner:TANGSHAN QIAO TECH LTD

Esterase activated chemiluminescent probe for microbiological detection as well as preparation method and application of esterase activated chemiluminescent probe

The invention belongs to the technical field of micromolecular chemiluminescent materials, and particularly relates to an esterase activated chemiluminescent probe for microbiological detection as well as preparation and application of the esterase activated chemiluminescent probe. The chemiluminescent probe disclosed by the invention is a compound prepared from an adamantane-dioxetane skeleton (AD-CL), and the chemiluminescent probe comprises two compounds which are named as ACCL or BUCL; the compound with the structure can be activated by esterase to generate chemiluminescence. The esterase for microbial detection comprises enzymes which are contained in escherichia coli, staphylococcus aureus and salmonella and can hydrolyze acetyl ester groups, butyryl ester groups, hexanoyl ester groups or capryloyl ester groups. The chemiluminescent probe can be used for responding to various esterases in vitro, and can also be used for microbiological detection and clinical disease diagnosis.
Owner:FUDAN UNIVERSITY

Exosome multi-target detection method based on nano-frame multi-satellite mode

According to the exosome multi-target detection method based on the nano-frame multi-satellite mode, a high-stability tetrahedron is used as a core skeleton, multiple high-protein-affinity nucleic acid aptamer tongs are assembled and matched according to needs to construct a high-reproducibility biomarker recognition element, a molecular form with multiple satellites wrapping exosome is constructed, and the exosome multi-target detection method based on the nano-frame multi-satellite mode is obtained. According to the method, a'free satellite 'element is formed, and flow cytometry is utilized to detect the particle size and output signals with ultralow background interference, so that multiple detection requirements of different tumors on different expression levels of different markers in different development processes can be met, and an identification-separation-detection integrated high-specificity exosome detection strategy is realized. Clinical examination and diagnosis requirements serve as fundamental guidance, detection potential is excavated on an existing basic flow platform, instrument detection particle size limitation is turned into background killer, a new instrument detection thought is widened, detection performance is improved, exosome encrypted information decoding is accelerated, and the transformation progress of clinical disease prevention and treatment and tumor diagnosis and treatment is promoted and guided.
Owner:CHONGQING MEDICAL UNIVERSITY

High-channel clinical microelectrode array intelligent brain function positioning system and method

The invention discloses a high-channel clinical microelectrode array intelligent brain function positioning system and method, and belongs to the field of electronic information and the technical field of clinical disease diagnosis and treatment. The system comprises a microelectrode array implanted in the brain, a signal processing and transmission unit and a signal identification unit. The microelectrode array adopts a multi-channel design, so that neural electrophysiological signals and transmitter chemical signals in different depths and directions can be synchronously detected, and the resolution ratio of a single cell level is achieved. The signal processing and transmission unit is responsible for signal acquisition, amplification and transmission and applying electrical stimulation; and the signal identification unit carries out real-time processing on the signal through a convolutional neural network algorithm, rapidly identifies a target nucleus and realizes accurate positioning. The nerve cell discharge and transmitter release can be monitored in real time at different depths and in different directions, rapid and accurate target spot positioning can be achieved by means of an advanced intelligent algorithm, and a more reliable basis is provided for DBS surgery.
Owner:AEROSPACE INFORMATION RES INST CAS

Substituted imidazoquinoxaline compound and application thereof

The invention provides a substituted imidazo quinoxaline compound and application thereof. In particular, the present invention provides a compound of the following Formula II: wherein A1-A3, B1-B4, and R1-R2 are defined herein, a pharmaceutically acceptable salt or prodrug thereof. The compounds of formula II are kinase inhibitors. Therefore, the compound provided by the invention can be used for treating clinical diseases caused by DDR function deficiency, such as cancer. # imgabs0 #
Owner:IMPACT THERAPEUTICS (SHANGHAI) INC +1

Whole body organ metabolism network analysis method, device and equipment and storage medium

ActiveCN119896488AComputerised tomographsCharacter and pattern recognitionMetabolic network analysisImage pair
The invention relates to a whole body organ metabolism network analysis method and device, equipment and a storage medium. The method comprises the steps that a PET image of a subject is collected, an SUV image, a Ki image and TAC data are obtained according to the PET image, and physiological information, clinical pathology information and daily habit information of the subject are collected; performing metabolism feature extraction based on the PET image, the SUV image and the Ki image corresponding to the region of interest, performing curve fitting on the TAC data of each organ by using the PET image, and representing metabolism disturbance under different organs by using a fitting residual error; constructing a whole body organ metabolism network according to the physiological information, the clinical pathological information, the daily habit information, the metabolic characteristics and the metabolic disturbance, and performing whole body organ metabolism analysis on the subject through the whole body organ metabolism network. According to the method, individualized differences are avoided, the metabolic association among organs of the whole body of a specific disease can be captured more comprehensively, and early diagnosis, accurate evaluation and individualized treatment of clinical diseases are facilitated.
Owner:SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI

Multi-dimensional quality cross validation evaluation method and system based on medical model training

The invention discloses a multi-dimensional quality cross validation evaluation method and system based on medical model training, and belongs to the technical field of medical file evaluation. Constructing a pathological feature sample library and a medical record archive library based on the pathological feature description words and the medical record archives, and classifying and recording the medical record archives through the pathological feature description words; according to the incidence process of the pathological characteristics, forming an incidence state transition relation chain and configuring incidence state verification nodes; in combination with a clinical pathology state time range of the pathology state verification node, screening associated cross-pathology features to form a cross-pathology label; and updating according to a verification node sequence to obtain a disease occurrence state cross relation chain, performing multi-dimensional quality evaluation on the medical record file, and outputting an evaluation value. According to the method, the accuracy and reliability of medical file quality evaluation are improved through multi-dimensional cross validation, high-quality medical record data support is provided for medical model training, and the method is suitable for medical record quality auditing, medical data treatment and medical model training data screening scenes of medical institutions at all levels.
Owner:南京吾爱网络技术有限公司 +1

Bacillus amyloliquefaciens H-6 and application thereof in preparation of medicine for treating or preventing porcine reproductive and respiratory syndrome virus infection

The invention belongs to the technical field of antiviral microecological preparations for livestock and poultry, and particularly relates to bacillus amyloliquefaciens H-6 and application thereof in preparation of drugs for treating or preventing porcine reproductive and respiratory syndrome virus infection. The preservation number of the bacillus amyloliquefaciens is CCTCC (China Center for Type Culture Collection) NO: M 20242740. The bacterial strain can reduce the infection activity of PRRSV cells, inhibit invasion and infection of PRRSV to the cells, and reduce proliferation of viruses on the cells. The anti-infection research on the cell level and the animal body level shows that the strain has a remarkable PRRSV resisting effect in vivo and in vitro, proliferation of viruses in a pig body can be reduced, damage of PRRSV infection to lung tissues and organs is reduced, the adverse effect of PRRSV infection to the body is effectively controlled, clinical disease symptoms of the pig during PRRSV infection can be weakened, and the porcine reproductive and respiratory syndrome treatment effect is improved. The composition can be used for preventing and controlling the porcine reproductive and respiratory syndrome.
Owner:HUAZHONG AGRI UNIV +1

Dual system method for assessing transmissibility of respiratory viruses and severity of diseases

The invention uses ex vivo human airway cultures to assess the transmissibility and replication ability of influenza and coronavirus strains. By comparing the pandemic influenza A H1N1 and the highly pathogenic influenza A H5N1 as reference virus strains, the spreading risks of various viruses are evaluated and classified. In addition, an in vitro model is used to assess the degree of alveolar fluid clearance (AFC) impairment caused by the virus as an indicator of the severity of the disease. The research reveals the relevance among the virus replication ability, human transmission, AFC damage degree and clinical disease severity of different influenza and coronavirus strains in bronchus.
Owner:CENT FOR IMMUNOLOGY & INFECTION LTD

A lumbar disc herniation postoperative recurrence risk prediction system based on domain offset correction

The application discloses a lumbar disc herniation postoperative recurrence risk prediction system based on domain offset correction, and relates to the technical field of medical data processing and clinical disease risk prediction. The system obtains the multi-modal clinical and imaging feature vectors and follow-up outcome data of a training queue and an independent verification queue, trains a central classifier to quantize and correct the multi-center data distribution difference, calculates and trims the importance weight of each training case, trains a survival analysis base learner based on the processed weight and performs stacked integration, determines a final deployment model in combination with an independent verification case queue, calls the final deployment model to perform reasoning on a target patient after lumbar disc herniation surgery, and outputs an individualized recurrence risk score, risk stratification and recurrence-free survival curve, thereby improving the robustness and reliability of the risk prediction system in a cross-center scenario, and being suitable for postoperative follow-up management of lumbar disc herniation and auxiliary clinical decision-making.
Owner:ZHEJIANG HOSPITAL

Herpes zoster skin lesion staging evaluation method and system based on AI image recognition

The invention discloses a herpes zoster skin lesion staging evaluation method and system based on AI image recognition, and relates to the technical field of herpes zoster skin lesion staging evaluation, and the method comprises the following steps: collecting herpes zoster skin lesion image data continuously recorded in multiple periods, synchronously embedding a time identifier in the collection process, and carrying out the time identification; recording the shooting moment, the illumination state and the shooting angle information of each frame of image in a unified manner to form an original image sequence; and based on the original image sequence, according to the progressive sequence of the time identifiers, performing adaptive sorting adjustment on the time intervals between the adjacent frames. According to the method, a stable skin lesion time evolution track is constructed through time identification and a continuous processing flow, so that staging reverse judgment caused by frame order disorder is avoided, and the continuity and reliability of herpes zoster skin lesion staging evaluation are improved; and meanwhile, color, area and texture changes are uniformly incorporated into natural time rhythm constraints, so that a staging result better conforms to a clinical disease course rule, and the safety of remote follow-up visit and intelligent evaluation is improved.
Owner:AFFILIATED HOSPITAL OF NANTONG UNIV

Immunogenic ZIKA virus compositions and uses thereof

The present invention relates to a vaccine for the prevention or treatment of a Zika virus infection and / or a Zika virus associated clinical illness of any severity. Further provided are methods for producing and inactivating Zika virus as well as processes for manufacturing compositions comprising Zika virus.
Owner:VALNEVA AUSTRIA GMBH

High-channel clinical microelectrode array intelligent brain function localization system and method

The application discloses a high-channel clinical microelectrode array intelligent brain function positioning system and method, and belongs to the fields of electronic information and clinical disease diagnosis and treatment technologies. The system comprises a microelectrode array implanted in the brain, a signal processing and transmission unit and a signal identification unit. The microelectrode array adopts a multi-channel design, can synchronously detect neural electrophysiological signals and transmitter chemical signals of different depths and directions, and has a resolution of a single cell level. The signal processing and transmission unit is responsible for signal acquisition, amplification and transmission, and applies electrical stimulation; the signal identification unit performs real-time processing on the signals through a convolutional neural network algorithm, quickly identifies target nuclei, and realizes accurate positioning. The application can realize real-time monitoring of neural cell discharges and transmitter releases at different depths and different directions, and can realize rapid and accurate target positioning with the aid of advanced intelligent algorithms, thereby providing a more reliable basis for DBS surgery.
Owner:AEROSPACE INFORMATION RES INST CAS

A humanized FKBP8 gene knock-in animal model and its construction method

The present invention provides a method for constructing a humanized FKBP8 gene knock-in animal model, comprising: (1) constructing a targeting vector for humanized FKBP8 gene knock-in, and transfecting the targeting vector, Cas9, and sgRNA into a fertilized egg of a donor animal; (2) transplanting a viable fertilized egg cell into the oviduct of a pseudo-pregnant animal to obtain an F0 generation animal, and identifying the F0 generation animal. An animal that is positive for homologous recombination is a chimeric animal; (3) mating the chimeric animal with a wild-type animal to obtain an F1 generation animal and identifying the F1 animal that is positive for homologous recombination is a humanized FKBP8 gene knock-in animal. The construction method provided by the present invention adopts the humanized FKBP8 gene sequence to replace the donor animal FKBP8 gene sequence to achieve the purpose of humanizing the donor animal FKBP8 gene, and successfully establishes a humanized FKBP8 gene knock-in animal model, which can be used to screen drugs targeting the FKBP8 gene and its products on the animal model or to study the pathogenesis and treatment mechanism of the FKBP8 gene and its products in related clinical diseases.
Owner:SHENZHEN INST OF ADVANCED TECH

Ultrasonic / magnetic resonance dual-mode nanoprobe and its preparation method and application

The present invention discloses an ultrasound / magnetic resonance dual-mode nanoprobe and its preparation method and application. The preparation method comprises the following steps: S1, preparing iron sulfide nanosheets (FeS) using ammonium ferrous sulfate, trisodium citrate, etc. as raw materials, and resuspending the FeS in ethanol to obtain an FeS ethanol solution; S2, adding perfluorohexane to the FeS anhydrous ethanol solution, and using an ultrasonic crusher under an ice bath to prepare a FeS / PFH suspension; S3, mixing the FeS / PFH suspension with a 1 mg / mL dopamine hydrochloride anhydrous ethanol solution, stirring at room temperature in the dark, and washing with pure water to obtain the final product, FeS / PFH / PDA nanomaterial. The present invention discloses an ultrasound / magnetic resonance dual-mode nanoprobe and its preparation method and application. The synthesis method for preparing the ultrasound / magnetic resonance dual-mode nanoprobe is simple and highly operable; the synthesized product is stable and reproducible, which is beneficial for biomedical research and clinical disease diagnosis.
Owner:SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG PROVINCIAL HOSPITAL)

Tandem mass spectrum ionization source for online detection of disease markers in tail end gas of expired gas of human body

The invention belongs to the technical field of mass spectrum ionization sources, provides a tandem mass spectrum ionization source for online detection of disease markers in tail end gas of expired gas of a human body, and aims to solve the problems of complex expired gas sampling, insufficient detection sensitivity and difficult real-time monitoring in the prior art. According to the ionization source device, real-time online expiration analysis of expired gas of a human body can be achieved, the expired gas end gas moment can be determined according to the change of the concentration of carbon dioxide in the expired gas, and therefore real-time analysis of disease markers in the expired gas end gas is achieved. According to the technical scheme, the design that double ionization sources are connected in series is adopted, and a funnel-shaped chemical ionization source is arranged at the front end and specially used for high-sensitivity detection of volatile organic compounds in exhaled air; the photoelectron ionization source is arranged at the rear end and used for monitoring the carbon dioxide concentration in real time and determining the end gas moment. According to the design, high sensitivity of organic matter detection and accurate monitoring of carbon dioxide concentration are both considered in a partitioned ionization mode. The efficient, sensitive and reliable mass spectrum ionization source device is provided for exhaled gas detection, automatic distinguishing of the front end and the tail end of exhaled gas and high-sensitivity analysis of disease markers in tail end gas can be achieved, the sampling process can be simplified, the detection efficiency can be improved, and the mass spectrum ionization source device has wide application prospects, can be suitable for various scenes and has wide application prospects. The method includes clinical disease early diagnosis, health monitoring and the like.
Owner:SHANDONG UNIV

Method, device and equipment for analyzing whole-body organ metabolic network and storage medium

The application relates to a whole-body organ metabolism network analysis method, device, equipment and storage medium. The method comprises the following steps: collecting a PET image of a subject, obtaining SUV images, Ki images and TAC data according to the PET image, and collecting physiological information, clinical pathology information and daily habit information of the subject; metabolism characteristics are extracted based on the PET images, SUV images and Ki images corresponding to the region of interest; the TAC data of each organ is curve-fitted by using the PET image, and the metabolism disturbance under different organs is represented by using the fitting residual error; a whole-body organ metabolism network is constructed according to the physiological information, clinical pathology information, daily habit information, metabolism characteristics and metabolism disturbance; and the whole-body organ metabolism of the subject is analyzed through the whole-body organ metabolism network. The application avoids individual differences, can more comprehensively capture the metabolism correlation among whole-body organs of a specific disease, and is helpful for early diagnosis, accurate evaluation and individualized treatment of clinical diseases.
Owner:SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI

Clinical disease queue data acquisition device

The invention relates to the field of data acquisition, in particular to a clinical disease queue data acquisition device which comprises a support mechanism, a lifting mechanism is arranged on the support mechanism, and a supporting mechanism is arranged on the support mechanism; the support mechanism comprises two fixing rods, arc-shaped holes are formed in the fixing rods, a fixing ring is rotationally connected into the two arc-shaped holes jointly, a limiting rod is inserted into the fixing ring, and a scanner is fixedly installed on the rod wall of the fixing rod. During use, the protective sleeve is taken down, the fixing rod is unfolded and supported through the supporting block, then the driving wheel descends to abut against the checklist paper, then the motor is started to drive the checklist paper to move below the scanner on the fixing rod, and then case data of the checklist are sequentially collected through the scanner. And the device can be conveniently carried to various environments to be used at any time.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Fibroblast preparation as well as preparation method and application thereof

The invention discloses a fibroblast preparation and a preparation method and application thereof, and belongs to the technical field of biomedical engineering, and the fibroblast preparation is prepared by mixing and compounding fibroblasts, a carrier and an active substance solution. The preparation method comprises the following steps: S1, cell pretreatment; s2, preparing a cross-linked collagen fiber hydrogel; s3, preparing an active substance solution; and S4, preparing the fibroblast preparation. By pretreating fibroblasts, activating the anti-inflammatory phenotype of the fibroblasts, promoting the fibroblasts to secrete collagen, loading the cells through collagenous fiber hydrogel and adding active substances, the skin lesion is repaired, meanwhile, type II immune excessive activation is inhibited, and the clinical disease performance of eczema mice is remarkably improved. The problems of limited skin disease treatment and skin lesion repair effects caused by low cell survival rate, poor carrier biocompatibility and poor active substance synergism in the prior art are solved, and the preparation method has the potential of preparing drugs for treating skin diseases.
Owner:SHENZHEN TAIYI SAIL BIOTECHNOLOGY CO LTD